Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-28
2006-11-28
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S254040, C544S121000, C544S367000, C544S374000, C548S953000
Reexamination Certificate
active
07141570
ABSTRACT:
The present invention provides antibacterial agents having the formula I described herein.
REFERENCES:
patent: 4705799 (1987-11-01), Gregory
patent: 5043443 (1991-08-01), Carlson et al.
patent: 5164510 (1992-11-01), Brickner
patent: 5182403 (1993-01-01), Brickner
patent: 5225565 (1993-07-01), Brickner
patent: 5231188 (1993-07-01), Brickner
patent: 5247090 (1993-09-01), Brickner
patent: 5523403 (1996-06-01), Barbachyn
patent: 5529998 (1996-06-01), Habich et al.
patent: 5547950 (1996-08-01), Hutchinson et al.
patent: 5565571 (1996-10-01), Barbachyn et al.
patent: 5627181 (1997-05-01), Riedl et al.
patent: 5652238 (1997-07-01), Brickner et al.
patent: 5684023 (1997-11-01), Riedl et al.
patent: 5688792 (1997-11-01), Barbachyn et al.
patent: 5698574 (1997-12-01), Riedl et al.
patent: 5792765 (1998-08-01), Riedl et al.
patent: 5827857 (1998-10-01), Riedl et al.
patent: 5843967 (1998-12-01), Riedl et al.
patent: 5861413 (1999-01-01), Habich et al.
patent: 5869659 (1999-02-01), Stolle et al.
patent: 5952324 (1999-09-01), Barbachyn et al.
patent: 5968962 (1999-10-01), Thomas et al.
patent: 5981528 (1999-11-01), Gravestock
patent: 6043266 (2000-03-01), Ennis et al.
patent: 6051716 (2000-04-01), Hutchinson et al.
patent: 6069145 (2000-05-01), Betts
patent: 6069160 (2000-05-01), Stolle et al.
patent: 6110936 (2000-08-01), Gravestock
patent: 6166056 (2000-12-01), Thomas et al.
patent: 6194441 (2001-02-01), Roberts et al.
patent: 6239152 (2001-05-01), Gordeev et al.
patent: 6271383 (2001-08-01), Gravestock
patent: 6313307 (2001-11-01), Ennis et al.
patent: 6362189 (2002-03-01), Hester et al.
patent: 6642238 (2003-11-01), Hester, Jr.
patent: 2002/0086900 (2002-07-01), Perrault et al.
patent: 1130016 (1999-11-01), None
patent: WO 94/01110 (1994-01-01), None
patent: WO 95/07271 (1995-03-01), None
patent: WO 95/14684 (1995-06-01), None
patent: WO 95/25106 (1995-09-01), None
patent: WO 96/13502 (1996-05-01), None
patent: WO 96/15130 (1996-05-01), None
patent: WO 96/23788 (1996-08-01), None
patent: WO 96/35691 (1996-11-01), None
patent: WO 97/09328 (1997-03-01), None
patent: WO 97/10223 (1997-03-01), None
patent: WO 97/10235 (1997-03-01), None
patent: WO 97/19089 (1997-05-01), None
patent: WO 97/21708 (1997-06-01), None
patent: WO 97/30981 (1997-08-01), None
patent: WO 97/30995 (1997-08-01), None
patent: WO 98/54161 (1998-12-01), None
patent: WO 99/03846 (1999-01-01), None
patent: WO 99/29688 (1999-06-01), None
patent: WO 99/37641 (1999-07-01), None
patent: WO 99/37652 (1999-07-01), None
patent: WO 99/40094 (1999-08-01), None
patent: WO 00/21960 (2000-04-01), None
patent: WO 01/40222 (2001-06-01), None
patent: WO 01/40236 (2001-06-01), None
patent: WO 01/44212 (2001-06-01), None
patent: WO 01/58885 (2001-08-01), None
patent: WO 01/81350 (2001-11-01), None
patent: WO 03/007870 (2003-01-01), None
M. Bianchi, et al., Eur. J. Med. Chem. (1988), 23, 45-52.
J. Org. Chem. 67(1), 24A (2002).
R. E. Notari, “Theory and Practice of Prodrug Kinetics,” Methods in Enzymology, 112:309-323 (1985).
N. Bodor, “Novel Approaches in Prodrug Design,” Drugs of the Future, 6(3):165-182, (1981).
H. Bundgaard, “Design of Prodrugs: Bioreversible-Derivatives for Various Functional Groups and Chemical Entities,” in Design of Prodrugs (H. Bundgaard, ed.), Elsevier, N.Y. (1985).
Harris Christina R.
Hester, Jr. Jackson Boling
Ashbrook Charles W.
Baude Eric J.
Pharmacia & Upjohn Company
Sackey Ebenezer
Shameem Golam M. M.
LandOfFree
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-aryl-2-oxazolidinone-5-carboxamides and their derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-aryl-2-oxazolidinone-5-carboxamides and their derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3663403